Facebook
Instagram
Pinterest
Reddit
Tumblr
X
Youtube
Home
About
News
Events
Shop
Directory
Contact Us
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
PsyNews.com
Home
About
News
Events
Shop
Directory
Contact Us
Home
Featured
Page 231
Featured
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Pα+ Psychedelic Bulletin #225: Q1 Lobbying Update; Individual vs. Group MDMA Therapy Study Launches; Australia Loosens Psychedelics Access Regulations; VA Launches “New” MDMA Trial
Three Brain Injuries, One Iboga Protocol, and What It Tells Us
The War on Drugs Was Never About Drugs. Psychedelic Healing Must Reckon With That.
A Dispatch from APA’s Annual Meeting: Psychedelics Return at an Awkward Moment for American Psychiatry
Momentum Amidst Tumult: The FDA Reshuffle, Approval Timelines, and the Compass-Usona Race
Psychedelics and Perception Part 2: The First Era of Research
Anima Mundi: Psychedelics and The Ensouled Earth
Mydecine To Supply Lead Drug Candidate, MYCO-001, for Multi-Site NIDA Grant-Funded...
MindMed Announces Strategic Research Collaboration with Sphere Health
PT265 – Jessica Cadoch, MA – Cooperation, Drug Exceptionalism, and 12-step...
Lobe Sciences and the World Boxing Association Announce Initiative Targeting mTBI...
Psychedelic Bulletin: Delix Raises $70m Series A; Toronto Gets Psychedelics Research...
PTSF79 – Psychedelic Facilitator Abuse and Space Holding Ethics with Dr....
MindMed Announces Appointment of Andreas Krebs and Carol Vallone as Directors...
MINDCURE Announces Commencement of Trading on the OTCQX Best Market
Load more